What 史赛克（北京）医疗器械有限公司 does

Stryker (Beijing) Medical Devices Co., Ltd. (史赛克（北京）医疗器械有限公司) is the Greater China operating subsidiary of Stryker Corporation, a Fortune 500 global medical technology company listed on the New York Stock Exchange under ticker SYK and headquartered in Kalamazoo, Michigan. The Beijing entity serves as Stryker's regional presence for China, marketing and selling medical devices and surgical equipment across three core product categories: Medical and Surgical Equipment (医疗和手术设备), Neurotechnology (神经技术), and Orthopedics, with explicit local focus on orthopedics, medical-surgical equipment, and neurointervention since entering the Chinese market. The portfolio draws on internally developed products as well as capabilities obtained through more than 40 years of Stryker acquisitions, including the Mako robotic-arm assisted surgery system (acquired via MAKO Surgical Corp. in 2013, with Mako Total Knee launched in 2017), K2M spinal products (acquired 2018), NOVADAQ fluorescence imaging (acquired 2017), and the Boston Scientific Neurovascular Division (acquired 2011). The subsidiary's localized product introductions reflect Trauson Holdings, acquired in 2013 specifically to access emerging-market orthopedic segments.\n\nThe Beijing subsidiary operates a B2B enterprise go-to-market model targeting healthcare institutions, hospitals, and medical professionals in China, with direct field sales, product demonstrations, clinical training, and ongoing technical support rather than distributor-led or transactional sales. Revenue is generated through hardware sales of medical devices, surgical equipment, orthopedic implants, and neurotechnology products to enterprise healthcare buyers, with pricing handled through enterprise contracts and not publicly disclosed. Stryker's competitive positioning rests on a diversified product portfolio, sustained R&D and acquisition-driven capability expansion, and brand recognition supported by 22 consecutive years on Fortune's World's Most Admired Companies list and 7 consecutive years on the World's Best Workplaces list.\n\nThe company is governed by Stryker Corporation's public-company structure (NYSE: SYK, IPO 1979, NYSE listing since 1997) with current Chairman and CEO Kevin Lobo overseeing global operations from Kalamazoo. The Chinese subsidiary operates with approximately 50 local employees and is registered in Beijing, China, holding Beijing ICP filings and a non-operating internet content license. Its product portfolio is anchored by flagship platforms such as Mako (robotic-arm assisted orthopedics), NOVADAQ (fluorescence imaging), K2M (spine), and the RUGGED ambulance stretcher, alongside the original oscillating saw technology that originated from Dr. Homer Stryker's 1947 patent.

Name

史赛克（北京）医疗器械有限公司

Legal name

Stryker Corporation

Website

https://strykerdata.com

Company type

Public

Founded year

1941

Operating status

Operating

Headcount range

11–50 employees

Short description

Stryker (Beijing) Medical Devices Co., Ltd. (史赛克（北京）医疗器械有限公司) is the Greater China operating subsidiary of Stryker Corporation (NYSE: SYK). The Beijing entity markets and sells orthopedic, medical-surgical, and neurointervention devices to hospitals and healthcare institutions across China via direct enterprise sales and clinical support.

Ownership category

akta.pro rank

Product category

Medical Devices and Surgical Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Orthopedic medical devices
• Surgical equipment
• Neurotechnology products
• Robotic surgery systems
• Medical implants

Headquarters

HQ city

Kalamazoo

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

1. Medical Device and Equipment Sales: Stryker generates revenue through the sale of medical devices, surgical equipment, orthopedic implants, neurotechnology products, and related solutions to healthcare institutions and professionals. The company operates in multiple segments including Medical and Surgical, Neurotechnology, and Orthopedics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Stryker (Beijing) Medical Devices Co., Ltd. is the Chinese regional operation of Stryker Corporation, selling medical and surgical equipment, neurotechnology products, orthopedic implants and devices, and robotic-assisted surgery systems to hospitals and healthcare providers across China. The portfolio spans joint replacement, trauma, spine, surgical navigation, fluorescence imaging, and patient handling/EMS equipment such as ambulance stretchers, sourced through acquisitions including MAKO Surgical, K2M and NOVADAQ.

Product overview

Stryker is a global medical technology company offering a diversified portfolio organized around four core product categories: Medical and Surgical Equipment (医疗和手术设备), Neurotechnology (神经技术), Orthopedics, and Surgical Robotics. The portfolio is anchored by internally developed products as well as significant acquired brands — including the MAKO surgical robotics system (acquired 2013; Mako Total Knee launched 2017), K2M spinal products (acquired 2018), and NOVADAQ fluorescence imaging (acquired 2017) — alongside established product lines such as the RUGGED™ ambulance stretcher and the oscillating saw series. Since entering the Chinese market, Stryker has localized its offerings in orthopedics, medical devices, and neurointervention.

Differentiator

Problem solved

Functional benefit

Brands

• MAKO: Robotic-arm assisted surgery platform for orthopaedic procedures including total knee replacement
• Circ-O-Lectric
• RUGGED

Products and services

• Mako Robotic-Arm Assisted Surgery System
• Medical and Surgical Equipment
• Neurotechnology Products
• Orthopedic Implants and Devices
• K2M Spinal Products
• NOVADAQ Fluorescence Imaging
• RUGGED Ambulance Stretcher

Quantifiable outcome

• First exceeded $10 billion in sales in 2016
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Johnson & Johnson (DePuy Synthes): Orthopedic, spine, and surgical solutions arm of J&J. Direct competitor across orthopedic implants, spine (K2M overlap), and trauma, with global brand presence comparable to Stryker.
• Smith & Nephew: UK-based medical device company competing across orthopedics, sports medicine, and advanced wound management. Direct competitor in orthopedic reconstruction and surgical equipment, with growing robotic surgery presence.
• Medtronic: Global medical device leader with overlapping portfolios in orthopedic, neurovascular, and surgical products. Direct competitor to Stryker across multiple Chinese hospital accounts and the most relevant head-to-head peer in the surgical robotics and spinal markets.
• Zimmer Biomet: Orthopedic implants and surgical robotics (Rosa) competitor with strong hip/knee replacement franchises. Competes directly with Stryker's Mako platform and is one of the closest comps in the orthopedic medical device space.

Emerging players

• Globus Medical: Spine and orthopedic robotics player (ExcelsiusGPS). Competes directly with Stryker's Mako and K2M-based spine portfolio in minimally invasive and robotic-assisted spine surgery.
• Intuitive Surgical: Da Vinci robotic surgery platform leader. While primarily soft-tissue focused, Intuitive is expanding into orthopedic and other specialties — emerging competitive overlap with Stryker's Mako in surgical robotics broadly.
• NuVasive: Spine surgery specialist focused on minimally invasive procedures. Direct overlap with Stryker's K2M-acquired spine portfolio in complex and minimally invasive spine markets.
• Brainlab: Surgical navigation and intraoperative imaging platform. Overlaps with Stryker's surgical navigation and fluorescence imaging (NOVADAQ) offerings across neurosurgery and orthopedics.
• Penumbra: Neurovascular thrombectomy and stroke intervention specialist. Competes with Stryker's neurovascular portfolio (ex-Boston Scientific Neurovascular) in ischemic stroke treatment.

Broad incumbents

• Boston Scientific: Diversified medical device incumbent. Stryker acquired Boston Scientific's neurovascular division in 2011, so Boston Scientific is a partial counterparty in Stryker's neurointervention portfolio and a broad competitor across multiple device categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%8F%B2%E8%B5%9B%E5%85%8B%EF%BC%88%E5%8C%97%E4%BA%AC%EF%BC%89%E5%8C%BB%E7%96%97%E5%99%A8%E6%A2%B0%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 史赛克（北京）医疗器械有限公司